Financial statements Winpharm
Balance sheet of Winpharm
Company age:
Age:
9 y. 1 m. 11 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of WINPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 5 962,25 | 22 096,50 | 26 527,62 | 30 277,61 | 21 457,05 | 15 294,84 |
| A. Fixed assets | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 | 1 000,00 |
| B. Current assets | 4 962,25 | 21 096,50 | 25 527,62 | 29 277,61 | 20 457,05 | 14 294,84 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 5 962,25 | 22 096,50 | 26 527,62 | 30 277,61 | 21 457,05 | 15 294,84 |
| A. Equity | -3 551,75 | 309,50 | 5 402,90 | 7 727,71 | -1 713,45 | -9 429,84 |
| B. Liabilities and provisions for liabilities | 9 514,00 | 21 787,00 | 21 124,72 | 22 549,90 | 23 170,50 | 24 724,68 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 9 514,00 | 21 787,00 | 21 124,72 | 22 549,90 | 23 170,50 | 24 724,68 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.